Aphria Sends Australian Partner First Shipment of Medical Cannabis

Aphria (TSX:APH; OTC:APHQF) announced the first shipment of medical cannabis product to its Australian-based partner Althea Company.

As quoted in the press release:

The shipment is part of a previously announced agreement between Aphria and Althea, in which Aphria will provide the Australian Company with packaged co-branded cannabis oil and dried flower products for the Australian medical cannabis market. Prior to shipment, the Australian Governments’ Office of Drug Control issued an import certificate and Health Canada issued an export certificate.

“We’re excited that Australian patients in need will now have access to Aphria-branded pharmaceutical-grade, clean and safe medical cannabis through our valuable partnership with Althea,” said Gregg Battersby, Vice-President, Commercial Strategy of Aphria.

Click here to read the full press release.

Source: www.newswire.ca